FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

784667001: Product containing precisely medroxyprogesterone acetate 160 milligram/1 milliliter conventional release suspension for injection (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
3765208013 Medroxyprogesterone acetate 160 mg/mL suspension for injection en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) IPS terminology module (core metadata concept)
3765209017 Product containing precisely medroxyprogesterone acetate 160 milligram/1 milliliter conventional release suspension for injection (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) IPS terminology module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Medroxyprogesterone acetate 160 mg/mL suspension for injection Is a Medicinal product (product) true Inferred relationship Some
Medroxyprogesterone acetate 160 mg/mL suspension for injection Has manufactured dose form Suspension for injection true Inferred relationship Some
Medroxyprogesterone acetate 160 mg/mL suspension for injection Has basis of strength substance (attribute) Medroxyprogesterone acetate true Inferred relationship Some 1
Medroxyprogesterone acetate 160 mg/mL suspension for injection Has concentration strength denominator unit mL true Inferred relationship Some 1
Medroxyprogesterone acetate 160 mg/mL suspension for injection Has concentration strength numerator unit mg true Inferred relationship Some 1
Medroxyprogesterone acetate 160 mg/mL suspension for injection Has precise active ingredient Medroxyprogesterone acetate true Inferred relationship Some 1

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

International Patient Summary

GB English

US English

Back to Start